Administration of general anesthetic agents to developing animals induces increased neuroapoptosis and subsequent neurocognitive or behavioral deficits.
1-10 The toxic effects are widespread and affect both neurons and oligodendrocytes.
11,12 The doses used to produce neurotoxic effects in the animals are analogous to those used in the clinical setting. The peak vulnerability to neuroapoptotic injury in rodents occurs at a stage of brain development equivalent to that of early gestation through infancy in humans.
7 In contrast to general anesthesia, spinal anesthesia in developing rats does not produce increased neuroapoptosis and is not associated with recognized subsequent abnormality.
13